To access this element change to forms mode OFF
Grant Award View - GA276591
A therapeutic solution for respiratory RNA viruses that corrects the...
GA ID:
GA276591
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
19-Dec-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2026
Value (AUD):
$1,448,333.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
A therapeutic solution for respiratory RNA viruses that corrects the patient’s TLR7-dependent inflammatory response
Purpose:
Respiratory virus infections such as COVID-19 and influenza cause mild to severe complications in humans, often resulting in patient death. With limitations in current treatments, there is an urgent need for novel therapeutics to combat these and other viruses. We propose a drug strategy that attacks a critical point in the viral pathogenesis process. With the knowledge of this control point, we developed a drug and will evaluate its efficacy for treating COVID-19, influenza and the common cold.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2019352
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
RMIT University
Recipient ABN:
49 781 030 034
Grant Recipient Location
Suburb:
Melbourne
Town/City:
Melbourne
Postcode:
3000
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, SA, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, IRELAND